Skip to content

house · Committee report

H. Rept. 119-746

TO REAUTHORIZE THE YOUNG WOMEN'S BREAST HEALTH EDUCATION AND AWARENESS REQUIRES LEARNING YOUNG ACT OF 2009

2026-07-13

Committees

Associated legislation

Text

Purpose and Summary

H.R. 4541, introduced on July 17, 2025, by Representatives Wasserman Schultz (D-FL) and Miller-Meeks (R-IA), reauthorizes continued funding for the Breast Cancer Education and Awareness Requires Learning Young Act (EARLY Act), which requires the Department of Health and Human Services (HHS), acting through the Centers for Disease Control and Prevention (CDC), to fund education, outreach, and provider training to close breast cancer screening and detection gaps for women under the age of 45 as well as women at a higher risk for breast cancer. In addition, the legislation reauthorizes nation-wide professional education campaigns, prevention research, and additional support for women diagnosed with breast cancer.

Background and Need for Legislation

Every year, about 42,000 women die from breast cancer in the United States.\1\ Among women in the U.S., breast cancer is the second most common cancer and the second leading cause of cancer death.\2\ Early detection of breast cancer can improve patient outcomes by catching cancer when it is easiest to treat.\3\ According to the Centers for Disease Control and Prevention (CDC), roughly 270,000 women are diagnosed with breast cancer on an annual basis.\4\ In 2022, a total of 27,136 new cases of breast cancer were reported in women younger than 45 years in the United States.\5\ About 10 percent of all breast cancer cases in the United States are found in women younger than 45.\6\ --------------------------------------------------------------------------- \1\Ctrs. for Disease Control and Prevention (CDC), Breast Cancer Awareness (Jul. 30, 2025), https://www.cdc.gov/cancer/features/breast- cancer.html. \2\CDC, Breast Cancer Statistics (Jun. 10, 2025); https:// www.cdc.gov/breast-cancer/statistics/index.html. \3\CDC, Health and Economic Benefits of Breast Cancer Interventions (Aug. 14, 2025), https://www.cdc.gov/nccdphp/priorities/breast- cancer.html. \4\CDC, supra note 1. \5\CDC, United States Cancer Statistics, Breast Cancer Among Women Younger Than 45 (Aug. 15, 2025), https://www.cdc.gov/united-states- cancer-statistics/publications/breast-cancer-among-young-women.html. \6\CDC, Bring Your Brave Campaign, About the Bring Your Brave Campaign (Sept. 24, 2024), https://www.cdc.gov/bring-your-brave/about/ index.html. --------------------------------------------------------------------------- First enacted in 2009, the EARLY Act has been credited with driving national progress in breast cancer awareness and prevention. The legislation directs the CDC to lead initiatives to increase knowledge of breast health and breast cancer among women, particularly those younger than 45 and those at higher risk for developing the disease.\7\ CDC's efforts to encourage breast health and prevent young women's breast cancer include, but are not limited to, promoting an educational campaign for health care professionals across HHS; conducting research on breast cancer prevention in younger women; and awarding grants to provide support and health information to young women diagnosed with cancer and other pre-neoplastic diseases. --------------------------------------------------------------------------- \7\CDC, Breast Cancer, Advisory Committee on Breast Cancer in Young Women (Sept. 3, 2025), https://www.cdc.gov/breast-cancer/php/advisory- committee/index.html. --------------------------------------------------------------------------- When diagnosed at the earliest stage, almost 98 percent of women diagnosed with breast cancer live for 5 years or more, compared to about 31 percent of those diagnosed at the most advanced stage.\8\ The CDC's National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides access to breast cancer screening and diagnostic services for low-income American women, including American Indian and Alaska Native women. The NBCCEDP also provides public education, outreach, patient navigation, and care coordination services to increase breast and cervical cancer screening rates and reach underserved populations. Over the past 35 years, NBCCEDP has served more than 6.6 million women, diagnosed 82,827 invasive breast cancers and 26,357 premalignant breast lesions, and diagnosed 5,422 invasive cervical cancers and 259,537 premalignant cervical lesions, of which 38 percent were high- grade.\9\ --------------------------------------------------------------------------- \8\Id. \9\CDC, About the National Breast and Cervical Cancer Early Detection Program (Feb. 20, 2026), https://www.cdc.gov/breast-cervical- cancer-screening/about/index.html. ---------------------------------------------------------------------------

Committee Action

On April 15, 2026, the Subcommittee on Health held a legislative hearing on H.R. 4541. The title of the hearing was ``Healthier America: Legislative Proposals to Improve Public Health.'' The Subcommittee received testimony from: Jamie Ulmer, MA, President and CEO, Healthcare Network Rachel F. Brem, MD, FACR, FSBI, Co-Founder, Chief Medical Officer, Brem Foundation to Defeat Breast Cancer and Professor and Vice-Chair Emeritus, The George Washington University Holly Ahern, MS, MT(ASCP), Associate Professor of Microbiology, State University of New York Adirondack Amy L. Ronneberg, MBA, Chief Executive Officer, National Marrow Donor Program Brian Wallach & Sandra Abrevaya, Co- Founders, I AM ALS Rene Quashie, JD, Vice President, Digital Health, Consumer Technology Association On May 13, 2026, the Subcommittee on Health met in open markup session and forwarded H.R. 4541, without amendment, to the full Committee by a voice vote. On May 21, 2026, the full Committee on Energy and Commerce met in open markup session and ordered H.R. 4541, as amended, favorably reported to the House by a record vote of 48 yeas and 0 nays.

Committee Votes

Clause 3(b) of rule XIII requires the Committee to list the record votes on the motion to report legislation and amendments thereto. The following reflects the record votes taken during the Committee consideration: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] Oversight Findings and Recommendations Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of rule XIII, the Committee held a hearing and made findings that are reflected in this report. New Budget Authority, Entitlement Authority, and Tax Expenditures Pursuant to clause 3(c)(2) of rule XIII, the Committee finds that H.R. 4541 would result in no new or increased budget authority, entitlement authority, or tax expenditures or revenues.

Congressional Budget Office Estimate

Pursuant to clause 3(c)(3) of rule XIII, at the time this report was filed, the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not available. Federal Mandates Statement The Committee adopts as its own the estimate of Federal mandates prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act. Statement of General Performance Goals and Objectives Pursuant to clause 3(c)(4) of rule XIII, the general performance goal or objective of this legislation is to improve the ability for communities to detect breast cancer and cervical cancer at early stages. Duplication of Federal Programs Pursuant to clause 3(c)(5) of rule XIII, no provision of H.R. 4541 is known to be duplicative of another Federal program, including any program that was included in a report to Congress pursuant to section 21 of Public Law 111-139 or the most recent Catalog of Federal Domestic Assistance. Related Committee and Subcommittee Hearings Pursuant to clause 3(c)(6) of rule XIII, the following related hearing was used to develop or consider H.R. 4541: On April 15, 2026, the Subcommittee on Health held a legislative hearing on H.R. 4541. The title of the hearing was ``Healthier America: Legislative Proposals to Improve Public Health.'' The Subcommittee received testimony from: Jamie Ulmer, MA, President and CEO, Healthcare Network; Rachel F. Brem, MD, FACR, FSBI, Co-Founder, Chief Medical Officer, Brem Foundation to Defeat Breast Cancer and Professor and Vice-Chair Emeritus, The George Washington University; Holly Ahern, MS, MT(ASCP), Associate Professor of Microbiology, State University of New York Adirondack; Amy L. Ronneberg, MBA, Chief Executive Officer, National Marrow Donor Program; Brian Wallach & Sandra Abrevaya, Co-Founders, I AM ALS; and, Rene Quashie, JD, Vice President, Digital Health, Consumer Technology Association. Committee Cost Estimate Pursuant to clause 3(d)(1) of rule XIII, the Committee adopts as its own the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974. At the time this report was filed, the estimate was not available. Earmark, Limited Tax Benefits, and Limited Tariff Benefits Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the Committee finds that H.R. 4541 contains no earmarks, limited tax benefits, or limited tariff benefits. Advisory Committee Statement No advisory committees within the meaning of section 5(b) of the Federal Advisory Committee Act were created by this legislation. Applicability to Legislative Branch The Committee finds that the legislation does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act. Section-by-Section Analysis of the Legislation Section 101. Short title Section 101 provides a short title of ``EARLY Act Reauthorization of 2025.'' Section 102. Reauthorization of the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009 Section 102 reauthorizes the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009 through 2031. Section 201. Short title Section 201 provides a short title of Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2025'' or the ``SCREENS for Cancer Act of 2025.'' Section 202. National Breast and Cervical Cancer Early Detection Program Section 202 reauthorizes the National Breast and Cervical Cancer Early Detection Program through 2030. This section also makes updates to the program to reduce disparities and support certain activities that improve cancer screening rates. Finally, this section requires that the Government Accountability Office (GAO) conduct a report on the program, including an estimate of the number of eligible individuals, the trends among the individuals served, and an assessment of underlying factors for such trends. Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): PUBLIC HEALTH SERVICE ACT * * * * * * * TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE * * * * * * * PART V--PROGRAMS RELATING TO BREAST HEALTH AND CANCER * * * * * * * SEC. 399NN. YOUNG WOMEN'S BREAST HEALTH AWARENESS AND SUPPORT OF YOUNG WOMEN DIAGNOSED WITH BREAST CANCER. (a) Public Education Campaign.-- (1) In general.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall conduct a national evidence-based education campaign to increase awareness of young women's knowledge regarding-- (A) breast health in young women of all racial, ethnic, and cultural backgrounds; (B) breast awareness and good breast health habits; (C) the occurrence of breast cancer and the general and specific risk factors in women who may be at high risk for breast cancer based on familial, racial, ethnic, and cultural backgrounds such as Ashkenazi Jewish populations; (D) evidence-based information that would encourage young women and their health care professional to increase early detection of breast cancers; and (E) the availability of health information and other resources for young women diagnosed with breast cancer. (2) Evidence-based, age appropriate messages.--The campaign shall provide evidence-based, age-appropriate messages and materials as developed by the Centers for Disease Control and Prevention and the Advisory Committee established under paragraph (4). (3) Media campaign.--In conducting the education campaign under paragraph (1), the Secretary shall award grants to entities to establish national multimedia campaigns oriented to young women that may include advertising through television, radio, print media, billboards, posters, all forms of existing and especially emerging social networking media, other Internet media, and any other medium determined appropriate by the Secretary. (4) Advisory committee.-- (A) Establishment.--Not later than 60 days after the date of the enactment of this section, the Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish an advisory committee to assist in creating and conducting the education campaigns under paragraph (1) and subsection (b)(1). (B) Membership.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall appoint to the advisory committee under subparagraph (A) such members as deemed necessary to properly advise the Secretary, and shall include organizations and individuals with expertise in breast cancer, disease prevention, early detection, diagnosis, public health, social marketing, genetic screening and counseling, treatment, rehabilitation, palliative care, and survivorship in young women. (b) Health Care Professional Education Campaign.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, and in consultation with the Administrator of the Health Resources and Services Administration, shall conduct an education campaign among physicians and other health care professionals to increase awareness-- (1) of breast health, symptoms, and early diagnosis and treatment of breast cancer in young women, including specific risk factors such as family history of cancer and women that may be at high risk for breast cancer, such as Ashkenazi Jewish population; (2) on how to provide counseling to young women about their breast health, including knowledge of their family cancer history and importance of providing regular clinical breast examinations; (3) concerning the importance of discussing healthy behaviors, and increasing awareness of services and programs available to address overall health and wellness, and making patient referrals to address tobacco cessation, good nutrition, and physical activity; (4) on when to refer patients to a health care provider with genetics expertise; (5) on how to provide counseling that addresses long- term survivorship and health concerns of young women diagnosed with breast cancer; and (6) on when to provide referrals to organizations and institutions that provide credible health information and substantive assistance and support to young women diagnosed with breast cancer. (c) Prevention Research Activities.--The Secretary, acting through-- (1) the Director of the Centers for Disease Control and Prevention, shall conduct prevention research on breast cancer in younger women, including-- (A) behavioral, survivorship studies, and other research on the impact of breast cancer diagnosis on young women; (B) formative research to assist with the development of educational messages and information for the public, targeted populations, and their families about breast health, breast cancer, and healthy lifestyles; (C) testing and evaluating existing and new social marketing strategies targeted at young women; and (D) surveys of health care providers and the public regarding knowledge, attitudes, and practices related to breast health and breast cancer prevention and control in high-risk populations; and (2) the Director of the National Institutes of Health, shall conduct research to develop and validate new screening tests and methods for prevention and early detection of breast cancer in young women. (d) Support for Young Women Diagnosed With Breast Cancer.-- (1) In general.--The Secretary shall award grants to organizations and institutions to provide health information from credible sources and substantive assistance directed to young women diagnosed with breast cancer and pre-neoplastic breast diseases. (2) Priority.--In making grants under paragraph (1), the Secretary shall give priority to applicants that deal specifically with young women diagnosed with breast cancer and pre-neoplastic breast disease. (e) No Duplication of Effort.--In conducting an education campaign or other program under subsections (a), (b), (c), or (d), the Secretary shall avoid duplicating other existing Federal breast cancer education efforts. (f) Measurement; Reporting.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall-- (1) measure-- (A) young women's awareness regarding breast health, including knowledge of family cancer history, specific risk factors and early warning signs, and young women's proactive efforts at early detection; (B) the number or percentage of young women utilizing information regarding lifestyle interventions that foster healthy behaviors; (C) the number or percentage of young women receiving regular clinical breast exams; and (D) the number or percentage of young women who perform breast self exams, and the frequency of such exams, before the implementation of this section; (2) not less than every 3 years, measure the impact of such activities; and (3) submit reports to the Congress on the results of such measurements. (g) Definition.--In this section, the term ``young women'' means women 15 to 44 years of age. (h) Authorization of Appropriations.--To carry out subsections (a), (b), (c)(1), and (d), there are authorized to be appropriated $9,000,000 for each of fiscal years 2022 through [2026] 2031. * * * * * * * TITLE XV--PREVENTIVE HEALTH MEASURES WITH RESPECT TO BREAST AND CERVICAL CANCERS SEC. 1501. ESTABLISHMENT OF PROGRAM OF GRANTS TO STATES. (a) In General.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may make grants to States on the basis of an established competitive review process for the purpose of carrying out programs-- (1) to screen women for breast and cervical cancer as a preventive health measure; (2) to provide appropriate referrals for medical treatment of women screened pursuant to paragraph (1) and to ensure, to the extent practicable, [the provision of appropriate follow-up services and support services such as case management] that appropriate follow-up services are provided; (3) to develop and disseminate public information and education [programs for the detection and control] programs for the prevention, detection, and control of breast and cervical cancer; (4) to improve the education, training, and skills of health professionals (including allied health professionals) in [the detection and control] the prevention, detection, and control of breast and cervical cancer; (5) to establish mechanisms through which the States can [monitor] ensure the quality of screening procedures for breast and cervical cancer, including the interpretation of such procedures[; and]; (6) to enhance appropriate support activities to increase breast and cervical cancer screenings, such as navigation of health care services, implementation of evidence-based or evidence-informed strategies to increase breast and cervical cancer screening in health care settings, and facilitation of access to health care settings; (7) to reduce disparities in breast and cervical cancer incidence, morbidity, and mortality, including in populations with higher than average rates; (8) to improve access to breast and cervical cancer screening and diagnostic services and reduce related barriers, including factors that relate to negative health outcomes; and [(6)] (9) to evaluate activities conducted under paragraphs (1) [through (5)] through (8) through appropriate surveillance or program-monitoring activities. (b) Grant and Contract Authority of States.-- (1) In general.--A State receiving a grant under subsection (a) may, subject to paragraphs (2) and (3), expend the grant to carry out the purpose described in such subsection through grants to public and nonprofit private entities and through contracts with public and private entities. (2) Certain applications.--If a nonprofit private entity and a private entity that is not a nonprofit entity both submit applications to a State to receive an award of a grant or contract pursuant to paragraph (1), the State may give priority to the application submitted by the nonprofit private entity in any case in which the State determines that the quality of such application is equivalent to the quality of the application submitted by the other private entity. (3) Payments for screenings.--The amount paid by a State to an entity under this subsection for a screening procedure under subsection (a)(1) may not exceed the amount that would be paid under part B of title XVIII of the Social Security Act if payment were made under such part for furnishing the procedure to a woman enrolled under such part. (c) Special Consideration for Certain States.--In making grants under subsection (a) to States whose initial grants under such subsection are made for fiscal year 1995 or any subsequent fiscal year, the Secretary shall give special consideration to any State whose proposal for carrying out programs under such subsection-- (1) has been approved through a process of peer review; and (2) is made with respect to geographic areas in which there is-- (A) a substantial rate of mortality from breast or cervical cancer; or (B) a substantial incidence of either of such cancers. [(d) Coordinating Committee Regarding Year 2020 Health Objectives.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish a committee to coordinate the activities of the agencies of the Public Health Service (and other appropriate Federal agencies) that are carried out toward achieving the objectives established by the Secretary for reductions in the rate of mortality from breast and cervical cancer in the United States by the year 2020. Such committee shall be comprised of Federal officers or employees designated by the heads of the agencies involved to serve on the committee as representatives of the agencies, and such representatives from other public or private entities as the Secretary determines to be appropriate.] * * * * * * * SEC. 1503. REQUIREMENTS WITH RESPECT TO TYPE AND QUALITY OF SERVICES. (a) Requirement of Prov

Source: https://api.congress.gov/v3/committee-report/119/hrpt/746